Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies
Eli Lilly (United States) · Indiana University – Purdue University Indianapolis · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
789
total citations
- FWCI
- 26.32
- Percentile
- 100%
- References
- 45
Citations per year
Authors
10- DMDavid MichelsonCorresponding
Eli Lilly (United States), Indiana University – Purdue University Indianapolis, Indiana University School of Medicine
- LALenard A. Adler
New York University
- TSThomas Spencer
Massachusetts General Hospital
- FWFrederick W. Reimherr
University of Utah
- SAScott A. West
Cancer Institute of Florida
Topics & keywords
Topics
Keywords
- Atomoxetine
- Placebo
- Atomoxetine hydrochloride
- Attention deficit hyperactivity disorder
- Psychology
- Randomized controlled trial
- Rating scale
- Adverse effect
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.